Dr Reddy’s Laboratories Ltd ADR

Yahoo Finance • 25 days ago

Immutep (IMMP) Scores Win After Announcing Deal With Indian Firm

We recently published 7 Best ASX Stocks to Buy Right Now.  Immutep Limited (NASDAQ:IMMP) is one of the best ASX stocks. Immutep Limited (NASDAQ:IMMP) is a biotechnology company developing therapies for cancer and autoimmune diseases. The... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 0.3% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

Update: Novo Nordisk Loses India Case to Halt Dr. Reddy's Production of Generic Semaglutide

(Updates with Novo Nordisk's response in the sixth paragraph.) Novo Nordisk (NVO) has lost an Ind PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • last month

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Asian equities traded in the US as American depositary receipts were tracking lower Tuesday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides

[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-la... Full story

Yahoo Finance • 3 months ago

Dr. Reddy's Laboratories Q2 Profit Rises

(RTTNews) - Dr. Reddy's Laboratories Ltd. (ROY) reported, under IFRS standards, that its second quarter profit attributable to equity holders of the parent company increased to INR 14.37 billion or INR 17.25 per share from INR 12.55 billio... Full story

Yahoo Finance • 3 months ago

Here are the major earnings before the open Friday

Major earnings expected before the bell on Friday include: * The Procter & Gamble Company (PG [https://seekingalpha.com/symbol/PG]) * General Dynamics Corporation (GD [https://seekingalpha.com/symbol/GD]) * Illinois Tool Works (ITW... Full story

Yahoo Finance • 3 months ago

Trump administration prepares probe targeting global drug pricing — FT

[Visiting Australian Prime Minister Anthony Albanese Meets With Trump At The White House] Kevin Dietsch/Getty Images News The Trump administration is preparing to launch a new investigation under Section 301 of the Trade Act of 1974 to de... Full story

Yahoo Finance • 3 months ago

Esperion settles patent dispute with Dr. Reddy’s over cholesterol drugs

[Artificial Intelligence helping improve human life and health digital concept] Vertigo3d/E+ via Getty Images * Esperion Therapeutics (NASDAQ:ESPR [https://seekingalpha.com/symbol/ESPR]) announced it has reached a settlement with Dr. Re... Full story

Yahoo Finance • 4 months ago

Dr. Reddy's Laboratories (NYSE:RDY): A Peter Lynch-Style GARP Investment

For investors looking for a systematic method for long-term appreciation at fair prices, the investment philosophy of Peter Lynch offers a useful framework. Lynch, who notably achieved 29.2% average yearly returns while managing Fidelity’s... Full story

Yahoo Finance • 4 months ago

Factbox-Indian textiles, jewellery slapped with 50% Trump tariff; pharma, phones exempt

NEW DELHI (Reuters) -The United States has doubled tariffs on Indian imports to as much as 50% as scheduled on Wednesday, hitting goods and produce as varied as garments, jewellery and shrimp. Sectors such as smartphones, pharmaceuticals... Full story

Yahoo Finance • 5 months ago

Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading

Asian equities traded in the US as American depositary receipts were slightly higher on Thursday mor PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 months ago

Dr. Reddy's Laboratories Breaks Above 200-Day Moving Average - Bullish for RDY

In trading on Monday, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) crossed above their 200 day moving average of $14.25, changing hands as high as $14.47 per share. Dr. Reddy's Laboratories Ltd. shares are currently trading up ab... Full story

Yahoo Finance • 5 months ago

DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Fits Peter Lynch's Growth at a Reasonable Price (GARP) Strategy

Peter Lynch’s investment approach, detailed in _One Up on Wall Street_, centers on finding companies with steady growth at fair prices—commonly called the Growth at a Reasonable Price (GARP) method. This approach highlights key financial m... Full story

Yahoo Finance • 6 months ago

Dr. Reddy's stock price target raised to INR1,100 by Jefferies

Investing.com - Jefferies has raised the price target on Dr. Reddy’s Laboratories Ltd. (DRRD:IN) (NYSE:RDY) to INR1,100.00 from INR1,010.00 while maintaining an Underperform rating on the stock. The price target adjustment follows Dr. Red... Full story

Yahoo Finance • 6 months ago

Doctor Reddy's: Fiscal Q1 Earnings Snapshot

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Wednesday reported profit of $165 million in its fiscal first quarter. On a per-share basis, the Hyderabad, India-based company said it had net income... Full story

Yahoo Finance • 6 months ago

Dr. Reddy’s Laboratories (RDY) and Alvotech Enter Into a Collaboration and License Agreement

Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years.Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a collaboration and license agreement to co... Full story

Yahoo Finance • 6 months ago

Dr. Reddy's Q1 Earnings Preview

* Dr. Reddy's (NYSE:RDY [https://seekingalpha.com/symbol/RDY]) is scheduled to announce Q1 earnings results on Wednesday, July 23rd, before market open. Over the last 1 year, RDY has beaten EPS estimates [https://seekingalpha.com/symbol... Full story

Yahoo Finance • 6 months ago

Dr. Reddy's Laboratories (RDY) Shares Cross Below 200 DMA

In trading on Tuesday, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) crossed below their 200 day moving average of $14.40, changing hands as low as $14.33 per share. Dr. Reddy's Laboratories Ltd. shares are currently trading off a... Full story

Yahoo Finance • 6 months ago

Morgan Stanley initiates coverage on Dr. Reddy's stock with Equalweight rating

Investing.com - Morgan Stanley initiated coverage on Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) with an Equalweight rating and a price target of INR1,298.00 on Monday. The research firm cited a balanced outlook for the Indian pharmaceutical... Full story